STRONG II trial : stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study
Source
BMJ open - ISSN 2044-6055-15:7 (2025) p. 1-11
Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease
Source
Cardiovascular diabetology - ISSN 1475-2840-24:1 (2025) p. 1-11
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Source
JHEP Reports - ISSN 2589-5559-7:6 (2025) p. 1-16
Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials
Source
JHEP Reports - ISSN 2589-5559-7:4 (2025) p. 1-11
MASH to cirrhosis : bridging the gaps in MASLD management
Source
Acta clinica Belgica - ISSN 1784-3286-79:6 (2025) p. 441-450